These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 23901046)
1. Oral naftopidil suppresses human renal-cell carcinoma by inducing G(1) cell-cycle arrest in tumor and vascular endothelial cells. Iwamoto Y; Ishii K; Sasaki T; Kato M; Kanda H; Yamada Y; Arima K; Shiraishi T; Sugimura Y Cancer Prev Res (Phila); 2013 Sep; 6(9):1000-6. PubMed ID: 23901046 [TBL] [Abstract][Full Text] [Related]
2. Naftopidil, a selective {alpha}1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma. Hori Y; Ishii K; Kanda H; Iwamoto Y; Nishikawa K; Soga N; Kise H; Arima K; Sugimura Y Cancer Prev Res (Phila); 2011 Jan; 4(1):87-96. PubMed ID: 21205739 [TBL] [Abstract][Full Text] [Related]
3. BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation. Wang L; Park P; Zhang H; La Marca F; Claeson A; Than K; Rahman S; Lin CY Int J Cancer; 2012 Oct; 131(8):1941-50. PubMed ID: 22275155 [TBL] [Abstract][Full Text] [Related]
4. Naftopidil, a selective alpha-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest. Kanda H; Ishii K; Ogura Y; Imamura T; Kanai M; Arima K; Sugimura Y Int J Cancer; 2008 Jan; 122(2):444-51. PubMed ID: 17918159 [TBL] [Abstract][Full Text] [Related]
5. Patrinia scabiosaefolia inhibits colorectal cancer growth through suppression of tumor angiogenesis. Chen L; Liu L; Ye L; Shen A; Chen Y; Sferra TJ; Peng J Oncol Rep; 2013 Sep; 30(3):1439-43. PubMed ID: 23820929 [TBL] [Abstract][Full Text] [Related]
6. Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma. Zhao G; Na R; Li L; Xiao H; Ding N; Sun Y; Han R Oncol Rep; 2017 Aug; 38(2):1021-1028. PubMed ID: 28656230 [TBL] [Abstract][Full Text] [Related]
7. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways. Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma. Sato A; Nagase H; Obinata D; Fujiwara K; Fukuda N; Soma M; Yamaguchi K; Kawata N; Takahashi S Int J Oncol; 2013 Nov; 43(5):1441-6. PubMed ID: 23969530 [TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice. Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids. Iwai A; Fujii Y; Kawakami S; Takazawa R; Kageyama Y; Yoshida MA; Kihara K Mol Cell Endocrinol; 2004 Oct; 226(1-2):11-7. PubMed ID: 15489000 [TBL] [Abstract][Full Text] [Related]
11. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells]. Li CY; Yao AM; Chang XN; Guo YH; Xu R Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines. Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743 [TBL] [Abstract][Full Text] [Related]
13. Piperazine-based Alpha-1 AR Blocker, Naftopidil, Selectively Suppresses Malignant Human Bladder Cells via Induction of Apoptosis. Nakagawa YU; Nagaya H; Miyata T; Wada Y; Oyama T; Gotoh A Anticancer Res; 2016 Apr; 36(4):1563-70. PubMed ID: 27069132 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma. Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190 [TBL] [Abstract][Full Text] [Related]
15. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma. Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126 [TBL] [Abstract][Full Text] [Related]
16. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells. Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition. Kausch I; Jiang H; Ewerdwalbesloh N; Doehn C; Krüger S; Sczakiel G; Jocham D BJU Int; 2005 Feb; 95(3):416-20. PubMed ID: 15679806 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas. Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051 [TBL] [Abstract][Full Text] [Related]
19. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia. Kojima Y; Sasaki S; Oda N; Koshimizu TA; Hayashi Y; Kiniwa M; Tsujimoto G; Kohri K Prostate; 2009 Oct; 69(14):1521-8. PubMed ID: 19544328 [TBL] [Abstract][Full Text] [Related]
20. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer. Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]